Guardant Health, Inc.
GH
$161.99
$9.646.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.04% | 7.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.04% | 7.25% | |||
| Cost of Revenue | 10.51% | 5.45% | |||
| Gross Profit | 11.33% | 8.24% | |||
| SG&A Expenses | 10.37% | 11.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.48% | 5.24% | |||
| Operating Income | -5.58% | -0.55% | |||
| Income Before Tax | -7.39% | 14.22% | |||
| Income Tax Expenses | -50.27% | 121.54% | |||
| Earnings from Continuing Operations | -7.20% | 12.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.20% | 12.78% | |||
| EBIT | -5.58% | -0.55% | |||
| EBITDA | -5.94% | -1.15% | |||
| EPS Basic | -5.90% | 14.51% | |||
| Normalized Basic EPS | -5.23% | 6.06% | |||
| EPS Diluted | -5.90% | 14.51% | |||
| Normalized Diluted EPS | -5.23% | 6.06% | |||
| Average Basic Shares Outstanding | 1.21% | 2.03% | |||
| Average Diluted Shares Outstanding | 1.21% | 2.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||